By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Development and commercialization of innovative therapies for use in medically supervised settings28K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States28K100.00%